Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2021

Schedule of basic and diluted per share results

	For the Three Months Ended				For the Six Months Ended
	June 30, 2021		June 30, 2020		June 30, 2021		June 30, 2020
Net loss	$	(1,151)	$	(694)	$	(1,919)	$	(980)
Weighted average shares outstanding for computation of basic per share results		7,718,000		5,130,000		6,981,000		5,109,000
Incremental shares from assumed exercise of stock options and warrants (a)		—		—		—		—
Adjusted weighted average shares for computation of diluted per share results		7,718,000		5,130,000		6,981,000		5,109,000

(a) Incremental shares from the assumed exercise of INDUS stock options are not included in periods where the inclusion of such shares would be anti-dilutive. The incremental shares from the assumed exercise of stock options and the Warrant for the 2021 second quarter and 2020 second quarter would have been 127,000 and 57,000, respectively. The incremental shares from the assumed exercise of the Warrant and stock options for the 2021 six month period and 2020 six month period would have been 126,000 and 55,000, respectively.

Schedule of options granted by INDUS under the Stock Option Plan to non-employee directors

		Fair Value per
	Number of	Option at
	Shares	Grant Date
Non-employee directors	111,258	$	11.00 - 14.17

Number of option holders at June 30, 2021 21

Schedule of unrecognized compensation expense related to nonvested stock options

Balance of Fiscal 2021	$	199
Fiscal 2022	$	372
Fiscal 2023	$	231
Fiscal 2024	$	111
Fiscal 2025	$	15

Summary of the activity under the INDUS Stock Option Plan

	For the Six Months Ended
	June 30, 2021			June 30, 2020
	Number of		Weighted Avg.	Number of		Weighted Avg.
	Shares		Exercise Price	Shares		Exercise Price
Outstanding at beginning of period	246,150	$	36.06	189,822	$	28.23
Adjustment for stock dividend	5,413	$	34.29	—	$	—
Granted	—	$	—	111,258	$	45.72
Exercised	(6,370)	$	26.46	(2,734)	$	29.25
Forfeited	(1,067)	$	37.49	—	$	—
Outstanding at end of period	244,126	$	35.50	298,346	$	34.74

Schedule of options by range of exercise prices

				Weighted Avg.
				Remaining
Range of Exercise Prices for	Outstanding at	Weighted Avg.		Contractual Life	Total Intrinsic
Outstanding Options	June 30, 2021	Exercise Price		(in years)	Value
$23.00 - $28.00	105,176	$	26.25	4.8	$	4,144
$28.00 - $32.00	14,073	$	29.84	4.0		504
$32.00 - $47.00	124,877	$	43.93	8.5		2,712
	244,126	$	35.50	6.6	$	7,360
Vested options	134,447	$	27.82	4.9	$	5,087

Schedule of accumulated other comprehensive income (loss)

	For the Six Months Ended
	June 30, 2021			June 30, 2020
Balance at beginning of period	$	(7,855)	$	(2,540)
Other comprehensive gain (loss) before reclassifications		1,969		(6,079)
Amounts reclassified		994		434
Net activity for other comprehensive gain (loss)		2,963		(5,645)
Balance at end of period	$	(4,892)	$	(8,185)

Schedule of components of accumulated other comprehensive income (loss)

	For the Three Months Ended
	June 30, 2021						June 30, 2020
			Tax						Tax
			(Expense)		Net-of				(Expense)		Net-of
	Pre-Tax		Benefit		Tax		Pre-Tax		Benefit		Tax
Reclassification included in net loss:
Loss on cash flow hedges (interest expense)	$	506	$	—	$	506	$	414	$	(83)	$	331
Change in other comprehensive loss:
Decrease in fair value of cash flow hedges		(1,022)		—		(1,022)		(1,038)		(77)		(1,115)
Other comprehensive loss	$	(516)	$	—	$	(516)	$	(624)	$	(160)	$	(784)

	For the Six Months Ended
	June 30, 2021						June 30, 2020
			Tax						Tax
			(Expense)		Net-of				(Expense)		Net-of
	Pre-Tax		Benefit		Tax		Pre-Tax		Benefit		Tax
Reclassification included in net loss:
Loss on cash flow hedges (interest expense)	$	994	$	—	$	994	$	549	$	(115)	$	434
Change in other comprehensive income (loss):
Increase (decrease) in fair value of cash flow hedges		1,969		—		1,969		(7,640)		1,561		(6,079)
Other comprehensive income (loss)	$	2,963	$	—	$	2,963	$	(7,091)	$	1,446	$	(5,645)

Restricted Stock Units (RSUs) [Member]

Schedule of options granted under RSU

	Time-based vesting			Performance-based vesting
		Fair Value per			Fair Value per
	Number of	Unit at		Number of	Option at
	Units	Grant Date		Shares	Grant Date
Employees	8,508	$	63.15	8,508	$	79.33
Non-employee directors	4,682	$	67.28	-
	13,190			8,508

Schedule of unrecognized compensation expense related to nonvested stock options

Balance of Fiscal 2021	$	425
Fiscal 2022	$	521
Fiscal 2023	$	282
Fiscal 2024	$	23

Schedule of compensation expense and related tax benefits for stock options

	For the Three Months Ended				For the Six Months Ended
	June 30, 2021		June 30, 2020		June 30, 2021		June 30, 2020
Compensation expense	$	291	$	160	$	505	$	282
Related tax benefit	$	—	$	34	$	—	$	62